Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
DOW Restructures AI Enterprise to Accelerate Battlefield Innovation
Pentagon AI chief Cameron Stanley described how the agency is aligning innovation offices and modernizing acquisition to operationalize AI.
4m read -
CROCS Turns OT Cyber Policy Into Action
Air Force tracks a 100-point OT cyber plan, convenes 100 experts monthly and pushes bases to rehearse operations through cyber disruptions.
13m watch -
Deploying Agentic AI Across Government
Learn how federal agencies are are governing, securing and scaling agentic AI tools.
24m watch Partner Content -
Air Force Pushes ‘AI-First’ Strategy
The strategy outlines a unified approach to data, talent and technology to accelerate decision‑making and strengthen readiness.
5m read
